AdimarketTM Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.

MIAMI LAKES, Florida—Adimarket, LLC, a subsidiary of the Global Stem Cells Group is a leading distributor of products for regenerative medicine providers, has announced a new stem cells product, exosomes, to its product portfolio. The product is available online via Adimarket’s website at and comes in a 1 mL vial and is available for 24-hour delivery after orders placed from any US city.

Exosomes contain a variety of genetic materials, such as mRNAs and microRNAs (miRNAs), which imply they may play a critical role in cell-to-cell communication. AdimarketTM Flow is procured and processed according to US standards and regulations established by the American Association of Tissue Banks (AATB) and the United States Food and Drug Association (FDA).

Exosomes are currently non-reactive and FDA approved.

Exosomes provide an exciting new treatment option for those suffering from degenerative diseases. As a next-generation therapy option, exosomes work by isolating the beneficial signals released by stem cells and use them rather than the stem cells themselves. Using exosomes as a viable therapeutic option makes sense, as they cause other cells to react and change their behavior accordingly. Research and application demonstrate that there is incredible therapeutic potential within extracellular vesicles, particularly exosomes.

Physicians exploring exosomes as a therapeutic option should familiarize themselves with their components and signal deliveries. Components of exosomes include MSCs, cytokines, chemokines, growth factors and hyaluronic acid (HA). They are able to deliver the following signals to target cells: anti-apoptotic, anti-fibrotic, pro-angiogenic and pro-differentiation.

Adimarket, LLC is a leading distributor of products for practitioners in the regenerative medicine field. The online market offers a vast portfolio of goods, ranging from office equipment to cellular- and tissue-based products. The Global Stem Cells Group, which owns Adimarket, continually develops and launches new products specifically for regenerative medicine practitioners to assure physicians have all they need to practice in their field safely and effectively.

To learn more about AdimarketTM Flow and all of Adimarket’s regenerative medicine products, visit

The organization recognizes Cuban doctors living outside of Cuba committed to delivering high-quality care

MIAMI LAKES, Florida—Dra. Maritza Novas, MSc, has been earned the honorary distinction of being named as a member of the Asociacion de Medicos Cubanos Altamente Especializados, or AMECAE. The organization recognizes Cuban doctors living outside of Cuba who provide excellence in care and research in highly specialized medical fields.

AMECAE is a non-profit organization composed of Cuban doctors living outside of Cuba that has challenged the medical community to provide the highest quality of care to patients worldwide. Each year, AMECAE welcomes a distinguished new class of doctors into the organization who have demonstrated that they have provided great service to their patients while contributing to helping their respective medical specialties overcome challenges and reach new levels of success.

Dra. Novas currently serves as the Global Stem Cells Group’s (ISSCA) Development and Research Director. The group is a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine. During her time with ISSCA, Dra. Novas has developed new standards for the stem cells industry through establishing new regenerative medicine protocols. She also serves as the head of the Stem Cells Center in Cancun, which provides stem cells treatments for patients who travel from the US who suffer from degenerative diseases.

Dra. Novas earned AMECAE’s honor as a result of her vast impact on the field of regenerative medicine. In her time as a doctor, Dra. Novas has made a profound impact on her patients through innovative treatments using regenerative medicine. Additionally, in her role as both a physician and researcher, Dra. Novas has trained countless other doctors in the area of regenerative medicine, which has led to their certification in the area.

To learn more about the Global Stem Cells Group and the work Dra. Novas is engaged in, visit